Anastrozole : interactions médicamenteuses
Anastrozole (Arimidex), inhibiteur de l'aromatase, présente 27 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 17 de niveau majeur, 0 de niveau modéré, 0 de niveau mineur et 10 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.
À quoi ressemble Anastrozole
Voir les 9 versionsRendus réalisés à partir des fiches produit des notices FDA : couleur, forme, taille et inscription. 9 versions documentées chez 15 laboratoires.
Interactions d'après la notice
Interactions majeures (17)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)
• Tamoxifen: Do not use in combination with ARIMIDEX. (notice Anastrozole, Interactions médicamenteuses)
Aucune interaction significative signalée (10)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)
Vérifiez Anastrozole avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.
Ouvrir dans le vérificateurCeci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.



